RLFTY OTC
MindMaze Therapeutics Holding S.A.
1W: -92.7%
1M: -45.4%
3M: -45.4%
YTD: -91.8%
1Y: -94.0%
3Y: -94.3%
$0.23
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$8M
+39.5% ▲
Gross Profit
$6M
+36.0% ▲
Operating Income
-$19M
+83.0% ▲
Net Income
-$17M
+82.6% ▲
EPS (Diluted)
$-1.37
+83.6% ▲
EBITDA
-$17M
+84.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $3M | $6M | $6M | $8M |
| YoY Growth | +0.0% | +0.0% | +83.1% | -0.8% | +39.5% |
| Cost of Revenue | $14M | $750K | $1M | $2M | $3M |
| Gross Profit | -$14M | $3M | $5M | $4M | $6M |
| Gross Margin | — | 77.4% | 79.4% | 71.2% | 69.4% |
| R&D Expenses | $14M | $19M | $13M | $91M | $1M |
| SG&A Expenses | $5M | $16M | $24M | $19M | $10M |
| Operating Expenses | $9M | $37M | $57M | $115M | $25M |
| Operating Income | -$9M | -$34M | -$52M | -$111M | -$19M |
| Operating Margin | — | -1033.0% | -855.8% | -1837.0% | -224.4% |
| Interest Expense | $100K | $797K | $205K | $330K | $215K |
| Income Before Tax | -$6M | -$36M | -$54M | -$112M | -$19M |
| Tax Expense | $2M | -$820K | -$4M | -$14M | -$2M |
| Net Income | -$8M | -$35M | -$51M | -$98M | -$17M |
| Net Margin | — | -1045.0% | -835.2% | -1627.4% | -203.4% |
| EPS (Diluted) | $-1.30 | $-3.86 | $-4.80 | $-8.35 | $-1.37 |
| EBITDA | -$19M | -$33M | -$49M | -$108M | -$17M |
| Shares Outstanding | 6M | 9M | 11M | 12M | 13M |